Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,257 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation

NCT00949650

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +11 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Clinical Trials and Research Associates Inc Montebello, California, United States
  • Innovative Medical Research of South Florida Miami, Florida, United States
  • Crescent City Research Consortiom Marrero, Louisiana, United States
View all 133 locations
View Trial Details
Completed

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

NCT00111839

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • University of Arkansas, Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • University of Southern California/Norris Cancer Center Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 58 locations
View Trial Details
Completed

Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT01395758

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford, California, United States
  • Washington D.C., District of Columbia, United States
  • Weston, Florida, United States
  • Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

AUY922 for Advanced ALK-positive NSCLC

NCT01752400

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

NCT01520389

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +27 more
Locations
  • University of Colorado Denver Aurora, Colorado, United States
  • Horizon Oncology Research, Inc. Lafayette, Indiana, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • South Texas Accelerated Research Therapeutics, LLC (START) San Antonio, Texas, United States
View Trial Details

Related conditions